بدائل البحث:
reported decrease » reported disease (توسيع البحث), reported depressive (توسيع البحث), reported case (توسيع البحث)
docking reported » docking revealed (توسيع البحث), testing reported (توسيع البحث), opening reported (توسيع البحث)
largest decrease » larger decrease (توسيع البحث)
marked decrease » marked increase (توسيع البحث)
reported decrease » reported disease (توسيع البحث), reported depressive (توسيع البحث), reported case (توسيع البحث)
docking reported » docking revealed (توسيع البحث), testing reported (توسيع البحث), opening reported (توسيع البحث)
largest decrease » larger decrease (توسيع البحث)
marked decrease » marked increase (توسيع البحث)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Data Sheet 1_Empagliflozin’s cardioenergetic protective effects through PPARα pathway modulation in heart failure.pdf
منشور في 2025"…Post-treatment, MRGlu and glucose uptake decreased markedly in the empagliflozin (EMPG) group, while no significant changes were observed in the fenofibrate (FF) group. …"
-
8
-
9
Table 2_An in-depth investigation of NAs-induced osteoporosis adverse events: a real-world, network toxicology and molecular docking analysis.xlsx
منشور في 2025"…In addition, the biological pathways and target proteins were studied by network toxicology and molecular docking techniques.</p>Results<p>Adefovir showed signs of adverse skeletal events at the two PT levels of OSTEOPOROSIS and BONE DENSITY DECREASED, while tenofovir showed signs of adverse skeletal events at the five PT levels of BONE DENSITY DECREASED, BONE LOSS, OSTEOPENIA, OSTEOPOROSIS and OSTEOPOROTIC FRACTURE. …"
-
10
Table 1_An in-depth investigation of NAs-induced osteoporosis adverse events: a real-world, network toxicology and molecular docking analysis.docx
منشور في 2025"…In addition, the biological pathways and target proteins were studied by network toxicology and molecular docking techniques.</p>Results<p>Adefovir showed signs of adverse skeletal events at the two PT levels of OSTEOPOROSIS and BONE DENSITY DECREASED, while tenofovir showed signs of adverse skeletal events at the five PT levels of BONE DENSITY DECREASED, BONE LOSS, OSTEOPENIA, OSTEOPOROSIS and OSTEOPOROTIC FRACTURE. …"
-
11
Table 3_An in-depth investigation of NAs-induced osteoporosis adverse events: a real-world, network toxicology and molecular docking analysis.xlsx
منشور في 2025"…In addition, the biological pathways and target proteins were studied by network toxicology and molecular docking techniques.</p>Results<p>Adefovir showed signs of adverse skeletal events at the two PT levels of OSTEOPOROSIS and BONE DENSITY DECREASED, while tenofovir showed signs of adverse skeletal events at the five PT levels of BONE DENSITY DECREASED, BONE LOSS, OSTEOPENIA, OSTEOPOROSIS and OSTEOPOROTIC FRACTURE. …"
-
12
-
13
-
14
-
15
-
16
-
17
-
18
Data Sheet 1_Natural active ingredients targeted inflammatory cytokines and major blinding eye diseases: a two-sample Mendelian randomization and molecular docking analysis.docx
منشور في 2025"…This process was performed using AutoDock and PyMOL software.</p>Results<p>The results indicated that IL-18 (OR: 1.134, 95% CI: 1.009–1.275, P = 0.034) and PDGF-BB (OR: 0.804, 95% CI: 0.678–0.954, P = 0.012) had protective effect on AMD; Genetically predicted RANTES had protective effect on glaucoma (OR: 0.886, 95% CI: 0.810–0.969, P = 0.008); IL-10 had protective effect on DR (OR: 0.871, 95% CI: 0.759–0.999, P = 0.048); GROa may be associated with increased myopia risk (OR: 1.230, 95% CI: 1.046–1.446, P = 0.012); Eotaxin (OR: 1.089, 95% CI: 1.018–1.165, P = 0.013), FGF2 (OR: 1.183, 95% CI: 1.004–1.393, P = 0.045) and GROa (OR: 1.053, 95% CI: 1.000–1.109, P = 0.049) were associated with increased cataract risk, while IL-1RA may be associated with decreased cataract risk. …"
-
19
Data Sheet 1_In silico molecular studies of Phosphinogold(I) thiocarbohydrate complexes: insights into multi-target anticancer mechanisms.docx
منشور في 2025"…Complex 13 demonstrated high in vitro activity against prostate, colon, and breast cancer cell lines (IC50 = 0.03, 0.25, and 0.07 μM respectively), collaborating with a significant interaction with Human Epidermal Growth Factor Receptor 2 (HER2) (–71.15 kcal/mol binding affinity) in silico. While acetylation decreased binding affinity; it enhanced cellular activity as reported in in vitro studies indicative of the need to balance lipophilicity and binding strength in future ligand design.…"
-
20